Labcorp: Ascension Deal Will Earn $550 Million in 2023

By Robert Michel | From the Volume XXX No. 4 – March 6, 2023 Issue

PUBLICLY TRADED LABORATORY COMPANIES OFFERED INSIGHTS into how acquisitions of hospital lab operations and outreach businesses add to their bottom lines, according to recent reports on full-year 2022 and fourth quarter earnings.  Last year was a busy one…

Read More

---

Eight Macro Trends for Clinical Labs in 2023

By Robert Michel | From the Volume XXX, No. 1 – January 3, 2023 Issue

CEO SUMMARY: Laboratory administrators and pathologists will want to carefully study eight important trends that will guide their business strategies in 2023. Many of these macro trends center on financial and operational difficulties and ways to steer around these obstacles. Anothe…

Read More

---

Getting the Jump on Solving Major Lab Issues

By R. Lewis Dark | From the Volume XXIX, No. 14 – October 10, 2022 Issue

Observant laboratory managers and pathologists will note a recurring theme among the business intelligence briefings in this issue of The Dark Report: Solutions to major challenges require proactive steps.  A case in point comes…

Read More

---

AI Fuels New Efforts in Computational Pathology

By Robert Michel | From the Volume XXIX, No. 14 – October 10, 2022 Issue

CEO SUMMARY: Computational pathology combines technology and data science to improve laboratory medicine. Mayo Clinic is exploring how this new model can improve productivity and diagnostic accuracy in ways that even labs at smaller hospitals can put into practice. Success will stem…

Read More

---

Innovation Showcased at Executive War College

By Robert Michel | From the Volume XXIX, No. 7 – May 16, 2022 Issue

CEO SUMMARY: This year’s Executive War College on Laboratory and Pathology Management proved to be a high-energy event. A record 900 attendees showed up and responded enthusiastically to visions and predictions of a post-COVID-19 healthcare system that hungers for large volumes of…

Read More

---

IVD Firms Grow During 2022, but COVID-19 Revenue Dropped

By Robert Michel | From the Volume XXIX, No. 7 – May 16, 2022 Issue

MOST MAJOR IN VITRO DIAGNOSTICS (IVD) MANUFACTURERS started strong in 2022 as their base businesses regained steam and made up for the significant falloff in COVID-19 diagnostic test revenue.  During first quarter 2022 earnings calls with invest…

Read More

---

April 25, 2022 Intelligence: Late-Breaking Lab News

By Robert Michel | From the Volume XXIX, No. 6 – April 25, 2022 Issue

In a sign that awareness of medical diagnostic testing continues to grow during the SARS-CoV-2 pandemic, the Mayo Clinic announced it will invest $49 million to build a new laboratory space on its campus in Rochester, Minn. As part of the multi-year project, several clinical labs will eventual…

Read More

---

New Trends Reshaping Healthcare, Lab Testing

By Robert Michel | From the Volume XXIX, No. 4 – March 14, 2022 Issue

…

Read More

---

Pathology Firm’s Investment in AI Signals a New Trend

By Robert Michel | From the Volume XXIX, No. 3 – February 22, 2022 Issue

This is an excerpt of a 1,436-word article in the February 22, 2022 issue of  THE DARK REPORT (TDR). The full article is available to members of The Dark Intelligence Group. CEO SUMMARY: Australian artificial intelligence (AI) company Harrison.ai got AU$129 million from multiple inve…

Read More

---

Artificial Intelligence ‘Invades’ Pathology, Billing

By R. Lewis Dark | From the Volume XXIX, No. 3 – February 22, 2022 Issue

Predictions about the potential of artificial intelligence (AI) to transform nearly every area of healthcare are about to become reality. For the profession of laboratory medicine, AI is making speedy inroads into two areas. The first is anato…

Read More

---